NeoGenomics (NEO) News Today → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free NEO Stock Alerts $14.80 -0.19 (-1.27%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 9:51 PM | marketbeat.comBrown Advisory Inc. Acquires 1,397,397 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Brown Advisory Inc. raised its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 16.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,643,599 shares of the medical research company's stock after buying an addMay 14, 2024 | americanbankingnews.comNeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 14, 2024 | americanbankingnews.comNeoGenomics (NASDAQ:NEO) Shares Pass Below Two Hundred Day Moving Average of $16.05May 11, 2024 | finance.yahoo.comNeoGenomics, Inc. (NEO)May 10, 2024 | benzinga.comNeoGenomics Earnings Analysis: Q1 RecapMay 6, 2024 | marketbeat.com212,935 Shares in NeoGenomics, Inc. (NASDAQ:NEO) Acquired by Lisanti Capital Growth LLCLisanti Capital Growth LLC acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 212,935 shares of the medical research company's stock, valued at approximately $3,445,May 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for NeoGenomics Amid Strong Q1 Performance and Growth ProspectsMay 2, 2024 | finance.yahoo.comNeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comBTIG Research Trims NeoGenomics (NASDAQ:NEO) Target Price to $21.00BTIG Research dropped their price target on shares of NeoGenomics from $23.00 to $21.00 and set a "buy" rating on the stock in a research report on Thursday.May 2, 2024 | finance.yahoo.comNeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 1, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) PT Lowered to $20.00TD Cowen decreased their price target on shares of NeoGenomics from $21.00 to $20.00 and set a "buy" rating on the stock in a research note on Wednesday.May 1, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Rating Reiterated by BenchmarkBenchmark reiterated a "buy" rating and issued a $18.00 target price on shares of NeoGenomics in a report on Wednesday.May 1, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Research Coverage Started at Craig HallumCraig Hallum assumed coverage on NeoGenomics in a report on Wednesday. They set a "buy" rating and a $26.00 price target for the company.May 1, 2024 | au.finance.yahoo.comQ1 2024 Neogenomics Inc Earnings CallMay 1, 2024 | msn.comNeoGenomics in Fort Myers and Herc in Bonita announce earnings. How did they do?May 1, 2024 | finance.yahoo.comNeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...April 30, 2024 | msn.comNEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024April 30, 2024 | finance.yahoo.comNeoGenomics Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss NarrowsApril 30, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Trading Down 7.7% After Analyst DowngradeNeoGenomics (NASDAQ:NEO) Trading Down 7.7% After Analyst DowngradeApril 30, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Issues FY 2024 Earnings GuidanceNeoGenomics (NASDAQ:NEO) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.000-0.040 for the period, compared to the consensus estimate of -0.010. The company also issued revenue guidance of $650.0 millionillion-$660.0 millionillion, compared to the consensus estimate of $654.6 millionillion.April 30, 2024 | msn.comNeoGenomics beats top-line and bottom-line estimates; reaffirms FY24 outlookApril 30, 2024 | businesswire.comNeoGenomics Reports First Quarter 2024 ResultsApril 29, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Stock Price Up 7.1%NeoGenomics (NASDAQ:NEO) Trading Up 7.1%April 29, 2024 | markets.businessinsider.comNeogenomics earnings: here's what Wall Street expectsApril 29, 2024 | msn.comNeoGenomics Q1 2024 Earnings PreviewApril 29, 2024 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Federated Hermes Inc.Federated Hermes Inc. reduced its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 51.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 149,441 shares of the medical research company'April 29, 2024 | benzinga.comNeoGenomics Stock (NASDAQ:NEO), Short Interest ReportApril 27, 2024 | marketbeat.comJennison Associates LLC Buys 89,473 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Jennison Associates LLC lifted its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 17.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 591,556 shares of the medical research company's stock after buying an addiApril 25, 2024 | marketbeat.com69,986 Shares in NeoGenomics, Inc. (NASDAQ:NEO) Acquired by Semanteon Capital Management LPSemanteon Capital Management LP bought a new position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 69,986 shares of the medical research company's stock, valued at approximateApril 23, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Stock Price Up 7.4%NeoGenomics (NASDAQ:NEO) Shares Up 7.4%April 22, 2024 | markets.businessinsider.comLeerink Partners Keeps Their Buy Rating on NeoGenomics (NEO)April 18, 2024 | businesswire.comNeoGenomics Announces Senior Leadership PromotionsApril 9, 2024 | businesswire.comNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024April 1, 2024 | marketbeat.comRedwood Investments LLC Takes $2.40 Million Position in NeoGenomics, Inc. (NASDAQ:NEO)Redwood Investments LLC bought a new stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 148,264 shares of the medical research company's stoMarch 30, 2024 | marketbeat.comSG Americas Securities LLC Trims Position in NeoGenomics, Inc. (NASDAQ:NEO)SG Americas Securities LLC decreased its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 42.8% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 85,746 shares of the medical research company's stock after selling 64,199 shares duringMarch 27, 2024 | businesswire.comNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingMarch 21, 2024 | nasdaq.comCommit To Purchase NeoGenomics At $10, Earn 9.1% Annualized Using OptionsMarch 20, 2024 | msn.comNeogenomics Pokes Up On Unveiling ESG ReportMarch 20, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Trading Up 5.3%NeoGenomics (NASDAQ:NEO) Trading 5.3% HigherMarch 20, 2024 | businesswire.comNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportMarch 20, 2024 | marketbeat.comPublic Sector Pension Investment Board Sells 68,768 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Public Sector Pension Investment Board cut its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 30.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 157,684 shares of the medical rMarch 14, 2024 | barrons.comNeoGenomics Inc.March 12, 2024 | marketbeat.comNeoGenomics (NASDAQ:NEO) Trading Down 4%NeoGenomics (NASDAQ:NEO) Stock Price Down 4%March 12, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Cuts Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Adage Capital Partners GP L.L.C. decreased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 90.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,620 shares of the medical researchMarch 11, 2024 | au.finance.yahoo.comOmics Lab Services Market Report 2024 - Innovations in Genomics and Big Data AnalyticsMarch 9, 2024 | marketbeat.comSchroder Investment Management Group Purchases 529,178 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Schroder Investment Management Group raised its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 26.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,513,307 shares of the medical research company's stoMarch 1, 2024 | businesswire.comNeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceMarch 1, 2024 | marketbeat.comFederated Hermes Inc. Reduces Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)Federated Hermes Inc. reduced its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 18.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 310,088 shares of the medical research company'sFebruary 28, 2024 | finance.yahoo.comWall Street Analysts Predict a 29.57% Upside in NeoGenomics (NEO): Here's What You Should KnowFebruary 27, 2024 | marketbeat.comKestra Advisory Services LLC Grows Stake in NeoGenomics, Inc. (NASDAQ:NEO)Kestra Advisory Services LLC boosted its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 260.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 60,545 shares of the medical research company's stock afte Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. NEO Media Mentions By Week NEO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEO News Sentiment▼0.900.42▲Average Medical News Sentiment NEO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEO Articles This Week▼33▲NEO Articles Average Week Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Evotec News Beam Therapeutics News Catalyst Pharmaceuticals News Amphastar Pharmaceuticals News Agios Pharmaceuticals News BrightSpring Health Services News Keros Therapeutics News Sana Biotechnology News Novavax News Galapagos News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
